Definitive Healthcare Corp. $DH Shares Acquired by Cubist Systematic Strategies LLC

Cubist Systematic Strategies LLC boosted its holdings in Definitive Healthcare Corp. (NASDAQ:DH) by 2,456.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 144,284 shares of the company’s stock after acquiring an additional 138,640 shares during the quarter. Cubist Systematic Strategies LLC owned 0.13% of Definitive Healthcare worth $417,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Whetstone Capital Advisors LLC bought a new stake in shares of Definitive Healthcare during the 1st quarter worth $2,512,000. Two Sigma Investments LP raised its holdings in shares of Definitive Healthcare by 2,383.1% during the fourth quarter. Two Sigma Investments LP now owns 285,555 shares of the company’s stock worth $1,174,000 after acquiring an additional 274,055 shares in the last quarter. Pinnacle Associates Ltd. purchased a new stake in shares of Definitive Healthcare during the first quarter worth $751,000. Pinnacle Wealth Management Advisory Group LLC bought a new stake in shares of Definitive Healthcare during the 1st quarter worth about $751,000. Finally, Sone Capital Management LLC bought a new position in shares of Definitive Healthcare in the 4th quarter valued at approximately $953,000. 98.67% of the stock is owned by institutional investors.

Analysts Set New Price Targets

DH has been the topic of a number of recent analyst reports. Robert W. Baird set a $4.00 price objective on Definitive Healthcare in a research note on Friday, August 8th. Stifel Nicolaus boosted their target price on Definitive Healthcare from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Friday, August 8th. Finally, Wall Street Zen upgraded shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, June 21st. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Definitive Healthcare currently has an average rating of “Hold” and a consensus price target of $4.73.

Definitive Healthcare Stock Down 3.9%

Shares of DH stock opened at $3.98 on Thursday. The stock has a market cap of $569.70 million, a price-to-earnings ratio of -1.50 and a beta of 1.65. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.65 and a current ratio of 1.65. Definitive Healthcare Corp. has a 52-week low of $2.15 and a 52-week high of $5.68. The firm’s 50-day moving average is $3.96 and its 200-day moving average is $3.43.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.